An interventional study of Yoga Intervention in Sleep Disturbance, Stress and Anxiety, sponsored by Johns Hopkins University. Completed at 1 site in United States. Open to participants aged 18 Years to 85 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2014-05-26.
Sponsored by Johns Hopkins University · Not applicable, Interventional, and Treatment
This study aims to provide novel information on the feasibility of yoga interventions for secondary symptoms related to severe vision loss, such as sleep disturbances, negative mood states, fall risk and balance. This information will be important for determining safe, cost-effective and reliable practices for the benefits of yoga as an alternative means for improved health and well-being. A yoga intervention that is integrative and evidence-based will benefit the blind population through effective treatments and prevention of secondary symptoms as well as serve to inform rehabilitation specialists, educators, and clinicians in the future.
This study aims to provide novel information on the feasibility of yoga interventions for secondary symptoms related to severe vision loss, such as sleep disturbances, negative mood states, fall risk and balance. This information will be important for determining safe, cost-effective and reliable practices for the benefits of yoga as an alternative means for improved health and well-being. A yoga intervention that is integrative and evidence-based will benefit the blind population through effective treatments and prevention of secondary symptoms as well as serve to inform rehabilitation specialists, educators, and clinicians in the future.
308 studies on the registry are indexed under Vision Disorders; 81 are open to participants now.
This study's enrollment of 21 is below the median of 66 across 211 interventional studies indexed under Vision Disorders.
Browse Vision Disorders studies →Johns Hopkins University is the lead sponsor of 1,783 studies on the registry; 313 are open to participants now.
Of its 203 completed or terminated interventional studies of FDA-regulated products, 140 (69%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Behavioral: Yoga Intervention
Three yoga classes per week for 8 weeks.
Also known as: Yoga, Ashtanga
Static Balance
Measures will be assessed at baseline (Week 0) and immediately after the 8-week intervention at Week 8.
Time frame: Week 0 and Week 8.
Perceived Stress Scale
Measures will be assessed at baseline (Week 0) and immediately after the 8-week intervention at Week 8.
Time frame: Week 0 and Week 8
Profile of Mood States - Short Form
Measures will be assessed at baseline (Week 0) and immediately after the 8-week intervention at Week 8.
Time frame: Week 0 and Week 8
Exit Survey
The exist survey is administered immediately after the intervention during Week 8.
Time frame: Week 8
Fear of Falling Questionnaire
Measures will be assessed at baseline (Week 0) and immediately after the 8-week intervention at Week 8.
Time frame: Week 0 and Week 8
Treatment Validation
Three measures will be collected to assess the benefits of the AYT, compliance, fidelity of treatment and evaluate the participant's experience. 1. The Philadelphia Mindfulness Scale (PHLMS). 2. Practice/Homework Logs. 3. Treatment Fidelity.
Time frame: Week 0, Week 4 and Week 8
Physical Function
Body Mass Index (BMI), systemic blood pressure, and respiratory rate, the International Physical Activity Questionnaire (IPAQ) and flexibility measures.
Time frame: Week 0 and Week 8
This study is completed, as verified in May 2014. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Johns Hopkins University